PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
TGA threatens illegal semaglutide promoters with jail, $1m fines Advertisers and social media influencers have been warned against publicly spruiking the drug for the purposes of weight loss.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.
Diabetes medication shortage worsens There is not expected be enough dulaglutide in Australia to fill all prescriptions for type 2 diabetes patients until at least early 2023, the TGA has warned.
Shortage of diabetes drug flagged until 2023 While semaglutide supply will be intermittent, its current availability should be ‘enough for approved use’, the manufacturer has advised.
New diabetes medication shortage will impact patient care The semaglutide shortage is having a flow on effect, with dulaglutide now also in short supply until at least the end of August.